Brief: CStone Pharmaceuticals Says CEO & Management Increase Shareholding In Co By 1 Million Shares Between Oct 20 And 22
23/10/2025 02:23
Oct 23 (Reuters) - CStone Pharmaceuticals 2616.HK: CEO & MANAGEMENT INCREASE SHAREHOLDING IN CO BY 1 MILLION SHARES BETWEEN OCT 20 AND 22 Further company coverage: 2616.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on CStone Pharmaceuticals
See all newsBrief: CStone Pharmaceuticals Says CEO Purchases 496,000 Shares For Over HK$2.7 Million From Sept 17-22
Brief: CStone Pharmaceuticals Posts HY Loss Of Rmb252.3 Million
China's CStone Pharmaceuticals H1 revenue soars on drug sales
Brief: Cstone Pharmaceuticals Receives NMPA IND Approval For CS5007 In China
Brief: CStone Pharmaceuticals Says Directors And Senior Management Purchase 2.4 Million Shares In June 2026